Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07300059 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 23, 2025 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This is an open-label, randomized study evaluating the short-term glycemic effects of two concentrations of liquid metformin formulations (100 mg/mL and 250 mg/mL) compared with standard immediate-release metformin tablets in healthy adult subjects. Participants will receive single or short-term doses of study treatments in a randomized sequence. Blood glucose measurements and other glycemic indicators will be collected to assess short-term pharmacodynamic effects. Safety and tolerability will also be monitored.
Trial Details
NCT Number NCT07300059
Lead Sponsor Aspargo Labs, Inc
Conditions
(from sponsor)		 Healthy Volunteers
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov